A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients

A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients
Recruiting
99 years or below
All
Phase 2
50 participants needed

Brief description of study

The THINKER-NEXT research study is being done to determine whether it is safe to give a kidney transplant from a donor with hepatitis C to a patient without hepatitis C. The recipient will then be given a drug called Epclusa for 12 weeks to treat hepatitis C. Patients who are on the kidney transplant waitlist and do not have hepatitis C will be asked to participate. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hepatitis C,renal
  • Age: 99 years or below
  • Gender: All


Updated on 19 Feb 2024. Study ID: 842809

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.